OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
Kok Pin Ng, Hui Jin Chiew, Pedro Rosa‐Neto, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 41
Kok Pin Ng, Hui Jin Chiew, Pedro Rosa‐Neto, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Development of Apathy, Anxiety, and Depression in Cognitively Unimpaired Older Adults: Effects of Alzheimer’s Disease Pathology and Cognitive Decline
Maurits Johansson, Erik Stomrud, Per Johansson, et al.
Biological Psychiatry (2022) Vol. 92, Iss. 1, pp. 34-43
Open Access | Times Cited: 45
Maurits Johansson, Erik Stomrud, Per Johansson, et al.
Biological Psychiatry (2022) Vol. 92, Iss. 1, pp. 34-43
Open Access | Times Cited: 45
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease
Cristiano Schaffer Aguzzoli, Pâmela C.L. Ferreira, Guilherme Povala, et al.
JAMA Network Open (2023) Vol. 6, Iss. 11, pp. e2345175-e2345175
Open Access | Times Cited: 27
Cristiano Schaffer Aguzzoli, Pâmela C.L. Ferreira, Guilherme Povala, et al.
JAMA Network Open (2023) Vol. 6, Iss. 11, pp. e2345175-e2345175
Open Access | Times Cited: 27
Mild behavioral impairment in early Alzheimer’s disease and its association with APOE and BDNF risk genetic polymorphisms
Veronika Matušková, Kateřina Veverová, Dylan J. Jester, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
Veronika Matušková, Kateřina Veverová, Dylan J. Jester, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
Neuropsychiatric symptoms and white matter hyperintensities in older adults without dementia
Ioannis Liampas, Vasileios Siokas, Elli Zoupa, et al.
International Psychogeriatrics (2024) Vol. 36, Iss. 11, pp. 1051-1063
Closed Access | Times Cited: 5
Ioannis Liampas, Vasileios Siokas, Elli Zoupa, et al.
International Psychogeriatrics (2024) Vol. 36, Iss. 11, pp. 1051-1063
Closed Access | Times Cited: 5
Progress on early diagnosing Alzheimer’s disease
Yixin Chen, Murad Al‐Nusaif, Song Li, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 3, pp. 446-464
Open Access | Times Cited: 4
Yixin Chen, Murad Al‐Nusaif, Song Li, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 3, pp. 446-464
Open Access | Times Cited: 4
The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment
Marta Marquié, Fernando García‐Gutiérrez, Adelina Orellana, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1371-1371
Open Access | Times Cited: 10
Marta Marquié, Fernando García‐Gutiérrez, Adelina Orellana, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1371-1371
Open Access | Times Cited: 10
A narrative review on mild behavioural impairment: an exploration into its scientific perspectives
Mariagiovanna Cozza, Virginia Boccardi
Aging Clinical and Experimental Research (2023) Vol. 35, Iss. 9, pp. 1807-1821
Closed Access | Times Cited: 10
Mariagiovanna Cozza, Virginia Boccardi
Aging Clinical and Experimental Research (2023) Vol. 35, Iss. 9, pp. 1807-1821
Closed Access | Times Cited: 10
Neuropsychiatric symptoms in Alzheimer's continuum and their association with plasma biomarkers
Lin Huang, Qi Huang, Fang Xie, et al.
Journal of Affective Disorders (2023) Vol. 348, pp. 200-206
Closed Access | Times Cited: 10
Lin Huang, Qi Huang, Fang Xie, et al.
Journal of Affective Disorders (2023) Vol. 348, pp. 200-206
Closed Access | Times Cited: 10
Predicting cognitive decline from neuropsychiatric symptoms and Alzheimer's disease biomarkers: A machine learning approach to a population-based data
Jay Shah, Janina Krell-Roesch, Erica Forzani, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Jay Shah, Janina Krell-Roesch, Erica Forzani, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Parallel changes in cognition, neuropsychiatric symptoms, and amyloid in cognitively unimpaired older adults and those with mild cognitive impairment
Alyssa N. De Vito, Zachary J. Kunicki, Hannah E. Joyce, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access
Alyssa N. De Vito, Zachary J. Kunicki, Hannah E. Joyce, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access
Tau-PET pathology in the subregions of the amygdala and its associations with cognitive performance and neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease
Catarina Tristão‐Pereira, Stephanie Langella, Justin S. Sanchez, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access
Catarina Tristão‐Pereira, Stephanie Langella, Justin S. Sanchez, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access
Mapping the Neuropsychiatric Symptoms in Alzheimer’s Disease Using Biomarkers, Cognitive Abilities, and Personality Traits: A Systematic Review
Athanasios Chatzikostopoulos, Despina Μoraitou, Vasileios Papaliagkas, et al.
Diagnostics (2025) Vol. 15, Iss. 9, pp. 1082-1082
Open Access
Athanasios Chatzikostopoulos, Despina Μoraitou, Vasileios Papaliagkas, et al.
Diagnostics (2025) Vol. 15, Iss. 9, pp. 1082-1082
Open Access
Clinical Evolution of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia With Lewy Bodies in a Post‐Mortem Cohort
Lucy L. Gibson, Ragnhild Skogseth, Tibor Hortobágyi, et al.
International Journal of Geriatric Psychiatry (2025) Vol. 40, Iss. 5
Open Access
Lucy L. Gibson, Ragnhild Skogseth, Tibor Hortobágyi, et al.
International Journal of Geriatric Psychiatry (2025) Vol. 40, Iss. 5
Open Access
Unraveling the Potential Underlying Mechanisms of Mild Behavioral Impairment: Focusing on Amyloid and Tau Pathology
Efthalia Angelopoulou, Anastasia Bougea, Alexandros Hatzimanolis, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1164-1164
Open Access | Times Cited: 3
Efthalia Angelopoulou, Anastasia Bougea, Alexandros Hatzimanolis, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1164-1164
Open Access | Times Cited: 3
Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate
Sami Ouanes, Miriam Rabl, Christopher Clark, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Sami Ouanes, Miriam Rabl, Christopher Clark, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Neuropsychiatric Symptoms and Alzheimer Disease Biomarkers Independently Predict Progression to Incident Cognitive Impairment
Ganesh M. Babulal, Ling Chen, Samantha Murphy, et al.
American Journal of Geriatric Psychiatry (2023) Vol. 31, Iss. 12, pp. 1190-1199
Open Access | Times Cited: 7
Ganesh M. Babulal, Ling Chen, Samantha Murphy, et al.
American Journal of Geriatric Psychiatry (2023) Vol. 31, Iss. 12, pp. 1190-1199
Open Access | Times Cited: 7
Beyond memory impairment: the complex phenotypic landscape of Alzheimer’s disease
Stathis Argyriou, John F. Fullard, Josh M. Krivinko, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 713-722
Closed Access | Times Cited: 2
Stathis Argyriou, John F. Fullard, Josh M. Krivinko, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 713-722
Closed Access | Times Cited: 2
Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms
Brandon Frank, Michael J. Walsh, Landon Hurley, et al.
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. 3, pp. 1055-1073
Closed Access | Times Cited: 2
Brandon Frank, Michael J. Walsh, Landon Hurley, et al.
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. 3, pp. 1055-1073
Closed Access | Times Cited: 2
Neuropsychiatric symptoms in cognitive decline and Alzheimer’s disease: biomarker discovery using plasma proteomics
Miriam Rabl, Christopher Clark, Loı̈c Dayon, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024), pp. jnnp-333819
Closed Access | Times Cited: 2
Miriam Rabl, Christopher Clark, Loı̈c Dayon, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024), pp. jnnp-333819
Closed Access | Times Cited: 2
Modeling the progression of neuropsychiatric symptoms in Alzheimer’s disease with PET-based Braak staging
Arthur C. Macedo, Joseph Therriault, Cécile Tissot, et al.
Neurobiology of Aging (2024) Vol. 144, pp. 127-137
Open Access | Times Cited: 2
Arthur C. Macedo, Joseph Therriault, Cécile Tissot, et al.
Neurobiology of Aging (2024) Vol. 144, pp. 127-137
Open Access | Times Cited: 2
Subjective cognitive decline and anxious/depressive symptoms during the COVID-19 pandemic: what is the role of stress perception, stress resilience, and β-amyloid?
Müge Akinci, Gonzalo Sánchez‐Benavides, Anna Brugulat‐Serrat, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Müge Akinci, Gonzalo Sánchez‐Benavides, Anna Brugulat‐Serrat, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Neuropsychiatric symptoms as a prodromal factor in Alzheimer’s type neurodegenerative disease: A scoping review
Diego Alves Ferreira, Lorena Barbosa Cunha Macedo, Maria Paula Foss
The Clinical Neuropsychologist (2023) Vol. 38, Iss. 5, pp. 1031-1059
Closed Access | Times Cited: 5
Diego Alves Ferreira, Lorena Barbosa Cunha Macedo, Maria Paula Foss
The Clinical Neuropsychologist (2023) Vol. 38, Iss. 5, pp. 1031-1059
Closed Access | Times Cited: 5
Millipore xMap® Luminex (HATMAG-68K): An Accurate and Cost-Effective Method for Evaluating Alzheimer's Biomarkers in Cerebrospinal Fluid
Erika Oliveira Hansen, Natália Silva Dias, Ivonne Carolina Bolaños Burgos, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 12
Erika Oliveira Hansen, Natália Silva Dias, Ivonne Carolina Bolaños Burgos, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 12
Plasma‐derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community‐based study
Janina Krell‐Roesch, Isabella Zaniletti, Jeremy A. Syrjanen, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2023) Vol. 15, Iss. 3
Open Access | Times Cited: 4
Janina Krell‐Roesch, Isabella Zaniletti, Jeremy A. Syrjanen, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2023) Vol. 15, Iss. 3
Open Access | Times Cited: 4
Change in Depressive Symptoms and Longitudinal Regional Amyloid Accumulation in Unimpaired Older Adults
Catherine E. Munro, Michelle Farrell, Bernard Hanseeuw, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2427248-e2427248
Open Access | Times Cited: 1
Catherine E. Munro, Michelle Farrell, Bernard Hanseeuw, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2427248-e2427248
Open Access | Times Cited: 1
